secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcturus Therapeutics Holdings Inc. (ARCT)
CIK:        0001768224
Form:       8-K
Filed at:   2022-06-24T23:59:59+00:00
Accession:  0001193805-22-001014
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcturus stockholders approve 3.75M share increase to equity plan, raise director compensation caps
--------------------------------------------------------------------------------

- Stockholders approved amending 2019 Omnibus Equity Incentive Plan to add 3,750,000 shares of common stock.
- Annual director award limit raised from $500K to $2M for new directors, lead independent director, and non-employee chair; $1M for others.
- Plan amendment passed with 9,375,429 votes for, 8,044,751 against, and 286,830 abstentions (44.7% opposed).
- Directors elected, say-on-pay approved, and Ernst & Young ratified as auditor for fiscal 2022.
- Stockholders voted for an annual say-on-frequency vote; Board adopted every-year frequency.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1768224/000119380522001014/0001193805-22-001014-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1768224/000119380522001014/e621778_8k-arct.htm
  HTML page:      https://secwatch.observer/filing/0001193805-22-001014

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer